MedTrace Logo

Post-MI PET Scan Imaging of Inflammation

NCT02281305 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2014-11-03

No results posted yet for this study

Summary

Restoring the patency of the coronary vessels and providing the ischemic myocardium with reperfused blood can cause additional tissue damage. A key element of ischemia and reperfusion (I/R) injury and major determinant of the evolution of damage in the affected myocardium is the inflammatory response. The main objective of the study is to evaluate the efficacy of colchicine in reducing I/R injury by effectively modulating the inflammatory response in the reperfused myocardium.

Conditions

  • Acute Myocardial Infarction

Interventions

DRUG

Colchicine

Sponsors & Collaborators

  • Academy of Athens

    collaborator OTHER

  • G.Gennimatas General Hospital

    lead OTHER

Principal Investigators

  • Constantinos Anagnostopoulos, MD · Biomedical Research Foundation of Academy of Athens

  • Christos Angelidis, MD · Athens General Hospital "G. Gennimatas"

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-04-30

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02281305 on ClinicalTrials.gov